|
|
|
 |
 |
| |
 |
 |
|
David Edwards, Gordon McKay Professor of the Practice of Biomedical Engineering in the FAS faculty, also received $7.6 million to develop a new platform for needle-less vaccination using an inhaled nanoparticle spray. This work is specifically focused on tuberculosis and diphtheria vaccines, and involves collaboration with the research group of Dean Barry Bloom, who is an investigator on this grant. The grants are two of 43 involving researchers in 33 countries that were announced by the Bill & Melinda Gates Foundation on June 28. A total of $437 million was pledged from the Foundation, the Wellcome Trust, and the Canadian Institutes of Health Research Foundation. The grants are part of the Grand Challenges in Global Health initiative, launched two years ago by the Foundation in partnership with the National Institutes of Health. The goal is to create health tools that are not only effective, but also inexpensive to produce, easy to distribute, and simple to use in developing countries. For more information, visit the web site at http://www.gatesfoundation.org/default.htm.
Harvard Public Health NOW is published biweekly by the Office of Communications Harvard School of Public Health 665 Huntington Ave., SPH 1-1312 Boston, Massachusetts 02115 617-432-6052 Editor and Layout: Christina Roache Contributing Writers: Paula Hartman Cohen, Carol Cruzan Morton, Dianne Finkelstein Photos Credits: Suzanne Camarata, Richard Chase, Graham Ramsay, James Bagnell Archived Issues || HSPH Home Copyright, 2007, President and Fellows of Harvard College |
